Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026514
Filing Date
2025-08-13
Accepted
2025-08-13 16:16:25
Documents
75
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20250630_10q.htm   iXBRL 10-Q 1976870
2 EXHIBIT 10.1 ex_848901.htm EX-10.1 24461
3 EXHIBIT 31.1 ex_829072.htm EX-31.1 16047
4 EXHIBIT 31.2 ex_829073.htm EX-31.2 16392
5 EXHIBIT 32.1 ex_829074.htm EX-32.1 12138
11 logosml.jpg GRAPHIC 3626
  Complete submission text file 0001437749-25-026514.txt   8124722

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250630.xsd EX-101.SCH 63303
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20250630_cal.xml EX-101.CAL 45891
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250630_def.xml EX-101.DEF 426163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250630_lab.xml EX-101.LAB 377184
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250630_pre.xml EX-101.PRE 460267
78 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250630_10q_htm.xml XML 1369538
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 251211871
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)